• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    3/21/23 1:35:39 PM ET
    $ACDC
    $ADCT
    $ADMP
    $AG
    Oilfield Services/Equipment
    Energy
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACDC alert in real time by email

     

    On Tuesday, 74 companies achieved new lows for the year.

    Points of Interest From Today's 52-Week Lows:

    • First Majestic Silver (NYSE:AG) was the biggest company in terms of market cap to set a new 52-week low.
    • The smallest company by market cap to hit a new 52-week low was Dunxin Financial Hldgs (AMEX:DXF).
    • Qutoutiao (NASDAQ:QTT) made the largest move down on the session, with shares plummeting 57.39% to reach its 52-week low.
    • Angel Oak Financial (NYSE:FINS)'s stock rebounded the most, as it traded up 0.0% after dropping to a new 52-week low.

    The stocks that set new 52-week lows on Tuesday:

    • First Majestic Silver (NYSE:AG) stock dropped to a yearly low on Tuesday of $5.56. Shares traded down 24.19%.
    • Centerspace (NYSE:CSR) shares fell to $52.74 on Tuesday, setting a new 52-week low with a shift of up 0.28%.
    • ProFrac Holding (NASDAQ:ACDC) shares made a new 52-week low of $13.07 on Tuesday. The stock was down 7.84% for the day.
    • YS Biopharma Co (NASDAQ:YS) shares set a new 52-week low of $7.44. The stock traded down 8.82%.
    • Mineralys Therapeutics (NASDAQ:MLYS) shares moved down 5.39% on Tuesday to hit a new 52-week low of $13.54, drifting down 5.39%.
    • Microvision (NASDAQ:MVIS) shares hit a yearly low of $2.06. The stock was down 0.94% on the session.
    • Nuveen Preferred & Income (NYSE:JPI) stock broke to a new 52-week low of $16.24 on Tuesday. Shares of the company traded down 0.92%.
    • Orion Office REIT (NYSE:ONL) stock achieved a new 52-week low on Tuesday morning, hitting $5.73 and moving up 0.69%.
    • John Hancock Preferred (NYSE:HPF) stock achieved a new 52-week low on Tuesday morning, hitting $14.69 and moving down 0.41%.
    • Angel Oak Financial (NYSE:FINS) shares reached a new 52-week low of $12.33 on Tuesday morning, moving 0.0% (flat).
    • Consolidated Comms Hldgs (NASDAQ:CNSL) stock drifted down 0.62% on Tuesday morning to hit a new 52-week low of $2.37.
    • Grindrod Shipping Hldgs (NASDAQ:GRIN) stock hit a yearly low of $11.20. The stock was down 1.1% for the day.
    • Cohen & Steers Select (NYSE:PSF) stock dropped to a yearly low on Tuesday of $17.60. Shares traded down 1.79%.
    • OrganiGram Holdings (NASDAQ:OGI) stock hit $0.59 on Tuesday morning, setting a new 52-week low for a change of up 5.89%.
    • ADC Therapeutics (NYSE:ADCT) shares made a new 52-week low of $2.08 on Tuesday. The stock was up 1.19% for the day.
    • Nektar Therapeutics (NASDAQ:NKTR) stock hit a new 52-week low of $0.86. The stock was down 4.43% on the session.
    • Focus Universal (NASDAQ:FCUV) stock hit $3.54 on Tuesday morning, setting a new 52-week low for a change of down 2.62%.
    • Beachbody Co (NYSE:BODY) shares set a new yearly low of $0.49 this morning. The stock was down 2.28% on the session.
    • Selina Hospitality (NASDAQ:SLNA) shares reached a new 52-week low of $1.35 on Tuesday morning, moving down 1.43%.
    • Azure Power Global (NYSE:AZRE) stock dropped to a yearly low on Tuesday of $1.62. Shares traded down 4.97%.
    • Kore Group Holdings (NYSE:KORE) stock hit $1.22 on Tuesday morning, setting a new 52-week low for a change of up 10.0%.
    • Berkeley Lights (NASDAQ:BLI) shares moved down 7.06% on Tuesday to hit a new 52-week low of $1.15, drifting down 7.06%.
    • VBI Vaccines (NASDAQ:VBIV) stock broke to a new 52-week low of $0.23 on Tuesday. Shares of the company traded up 2.8%.
    • ImmunoPrecise Antibodies (NASDAQ:IPA) shares hit a yearly low of $2.90. The stock was up 0.65% on the session.
    • Solid Biosciences (NASDAQ:SLDB) shares moved up 2.44% on Tuesday to hit a new 52-week low of $3.63, drifting up 2.44%.
    • Nuveen Preferred (NYSE:JPT) shares made a new 52-week low of $16.05 on Tuesday. The stock was down 3.91% for the day.
    • Longeveron (NASDAQ:LGVN) stock drifted down 3.89% on Tuesday morning to hit a new 52-week low of $2.56.
    • SMX (Security Matters) (NASDAQ:SMX) stock hit a yearly low of $1.32. The stock was up 0.73% for the day.
    • Silvergate Capital (NYSE:SI) shares set a new yearly low of $1.46 this morning. The stock was down 11.31% on the session.
    • Portage Biotech (NASDAQ:PRTG) stock hit a yearly low of $2.59. The stock was down 5.3% for the day.
    • MIND C.T.I. (NASDAQ:MNDO) shares made a new 52-week low of $2.00 on Tuesday. The stock was down 11.3% for the day.
    • ReWalk Robotics (NASDAQ:RWLK) stock drifted down 1.34% on Tuesday morning to hit a new 52-week low of $0.66.
    • SELLAS Life Sciences Gr (NASDAQ:SLS) shares moved down 0.78% on Tuesday to hit a new 52-week low of $1.23, drifting down 0.78%.
    • MAIA Biotechnology (AMEX:MAIA) stock dropped to a yearly low on Tuesday of $3.10. Shares traded up 1.57%.
    • BM Technologies (AMEX:BMTX) stock dropped to a yearly low on Tuesday of $2.60. Shares traded down 3.64%.
    • Avalo Therapeutics (NASDAQ:AVTX) shares set a new 52-week low of $2.07. The stock traded up 1.85%.
    • Urban-gro (NASDAQ:UGRO) stock broke to a new 52-week low of $2.48 on Tuesday. Shares of the company traded up 1.56%.
    • Knightscope (NASDAQ:KSCP) shares set a new yearly low of $0.64 this morning. The stock was up 0.77% on the session.
    • E-Home Household Service (NASDAQ:EJH) stock broke to a new 52-week low of $0.10 on Tuesday. Shares of the company traded down 3.74%.
    • Atlis Motor Vehicles (NASDAQ:AMV) shares hit a yearly low of $0.67. The stock was up 0.71% on the session.
    • Aziyo Biologics (NASDAQ:AZYO) shares fell to $1.18 on Tuesday, setting a new 52-week low with a shift of down 15.17%.
    • Vaccinex (NASDAQ:VCNX) shares fell to $0.39 on Tuesday, setting a new 52-week low with a shift of down 2.52%.
    • FlexShopper (NASDAQ:FPAY) stock hit a new 52-week low of $0.74. The stock was down 1.92% on the session.
    • Adamis Pharmaceuticals (NASDAQ:ADMP) shares fell to $0.10 on Tuesday, setting a new 52-week low with a shift of up 3.06%.
    • SHF Hldgs (NASDAQ:SHFS) shares moved down 2.73% on Tuesday to hit a new 52-week low of $0.53, drifting down 2.73%.
    • Angion Biomedica (NASDAQ:ANGN) shares set a new yearly low of $0.47 this morning. The stock was up 0.1% on the session.
    • Sigmatron International (NASDAQ:SGMA) shares fell to $2.42 on Tuesday, setting a new 52-week low with a shift of down 20.77%.
    • CXApp (NASDAQ:CXAI) shares moved down 2.38% on Tuesday to hit a new 52-week low of $1.81, drifting down 2.38%.
    • Bullfrog AI Hldgs (NASDAQ:BFRG) stock achieved a new 52-week low on Tuesday morning, hitting $2.47 and moving up 2.39%.
    • Better Choice Co (AMEX:BTTR) stock broke to a new 52-week low of $0.41 on Tuesday. Shares of the company traded down 2.06%.
    • AgriFORCE Growing Systems (NASDAQ:AGRI) shares set a new yearly low of $0.65 this morning. The stock was down 4.62% on the session.
    • PolyPid (NASDAQ:PYPD) shares were down 2.62% for the day, having made a 52-week low of $0.50.
    • Check-Cap (NASDAQ:CHEK) shares reached a new 52-week low of $1.60 on Tuesday morning, moving down 41.9%.
    • Plus Therapeutics (NASDAQ:PSTV) stock dropped to a yearly low on Tuesday of $0.27. Shares traded 0.0% (flat).
    • Qutoutiao (NASDAQ:QTT) stock broke to a new 52-week low of $0.25 on Tuesday. Shares of the company traded down 57.39%.
    • Athenex (NASDAQ:ATNX) shares set a new yearly low of $0.98 this morning. The stock was down 18.26% on the session.
    • Soligenix (NASDAQ:SNGX) shares fell to $2.13 on Tuesday, setting a new 52-week low with a shift of up 4.4%.
    • SILO Pharma (NASDAQ:SILO) shares moved down 8.33% on Tuesday to hit a new 52-week low of $1.71, drifting down 8.33%.
    • IT Tech Packaging (AMEX:ITP) stock hit a yearly low of $0.44. The stock was down 0.02% for the day.
    • PolarityTE (NASDAQ:PTE) shares set a new 52-week low of $0.62. The stock traded down 1.32%.
    • Reliance Global Group (NASDAQ:RELI) stock achieved a new 52-week low on Tuesday morning, hitting $2.51 and moving down 1.55%.
    • Bellicum Pharmaceuticals (NASDAQ:BLCM) shares reached a new 52-week low of $0.27 on Tuesday morning, moving up 7.03%.
    • Dunxin Financial Hldgs (AMEX:DXF) stock hit a yearly low of $0.12. The stock was down 2.99% for the day.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ACDC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACDC
    $ADCT
    $ADMP
    $AG

    CompanyDatePrice TargetRatingAnalyst
    Avalo Therapeutics Inc.
    $AVTX
    4/9/2026$48.00Outperform
    Wolfe Research
    D/B/A Centerspace
    $CSR
    4/7/2026$72.00Neutral → Overweight
    Piper Sandler
    Avalo Therapeutics Inc.
    $AVTX
    4/6/2026$52.00Mkt Outperform
    Citizens
    First Majestic Silver Corp.
    $AG
    3/24/2026Market Perform → Outperform
    BMO Capital Markets
    Nektar Therapeutics
    $NKTR
    3/24/2026$70.00Neutral
    Wedbush
    Solid Biosciences Inc.
    $SLDB
    3/20/2026$26.00Buy
    Guggenheim
    Nektar Therapeutics
    $NKTR
    3/17/2026Buy
    TD Cowen
    Nektar Therapeutics
    $NKTR
    2/10/2026Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $ACDC
    $ADCT
    $ADMP
    $AG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Avalo Therapeutics with a new price target

    Wolfe Research initiated coverage of Avalo Therapeutics with a rating of Outperform and set a new price target of $48.00

    4/9/26 8:40:45 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Centerspace upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Centerspace from Neutral to Overweight and set a new price target of $72.00

    4/7/26 8:35:32 AM ET
    $CSR
    Real Estate Investment Trusts
    Real Estate

    Citizens initiated coverage on Avalo Therapeutics with a new price target

    Citizens initiated coverage of Avalo Therapeutics with a rating of Mkt Outperform and set a new price target of $52.00

    4/6/26 8:44:25 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for FAMOTIDINE issued to ATHENEX INC

    Submission status for ATHENEX INC's drug FAMOTIDINE (SUPPL-13) with active ingredient FAMOTIDINE has changed to 'Approval' on 01/07/2022. Application Category: ANDA, Application Number: 075684, Application Classification: Labeling

    1/12/22 4:41:30 AM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Safe Harbor Financial Applauds Historic Federal Cannabis Rescheduling Action, Citing Potential Benefits to Operator Economics, Deposit Quality, and Total Addressable Market

    DENVER, April 24, 2026 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a Safe Harbor Financial ("Safe Harbor" or the "Company") (NASDAQ:SHFS), a leading fintech platform serving the banking, lending, and financial services needs of the regulated cannabis and hemp industries, today issued the following statement in response to the Acting Attorney General's order moving state-licensed medical marijuana and FDA-approved cannabis products from Schedule I to Schedule III of the Controlled Substances Act, effective April 22, 2026. The order applies narrowly to FDA-approved cannabis products and qualifying state-licensed medical marijuana operators and does not extend to adult-use cannabis. "The fin

    4/24/26 8:15:00 AM ET
    $SHFS
    Finance: Consumer Services
    Finance

    Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

    SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced the closing of its underwritten public offering of $373.8 million of shares of its common stock. Nektar sold 4,062,500 shares of common stock in the offering, which includes 529,891 shares sold upon exercise in full by the underwriters of their option to purchase additional shares of common stock in the offering. The shares of common stock were sold at a public offering price of $92.00 per share. The gross proceeds to Nektar from the offering were approximately $373.8 million, before deducting underwritin

    4/23/26 4:15:00 PM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

    HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announced today the initiation of manufacturing activities and technology transfer with SpectronRx under a previously executed Master Services Agreement (MSA), in support of late-stage clinical manufacturing of Rhenium-186 and REYOBIQ. With SpectronRx serving as a second GMP manufacturing site alongside Radiomedix, and Rhenium-186 isotope supplied through Telix Pharmaceuticals, Plus strengthens the reliability of its multi-partner supply chain

    4/23/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Daniels Eric Joseph

    4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)

    4/22/26 5:00:04 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Rodman David Malcom

    4 - Mineralys Therapeutics, Inc. (0001933414) (Issuer)

    4/21/26 6:59:35 PM ET
    $MLYS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Daniels Eric Joseph

    3 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)

    4/21/26 5:00:06 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $30,000 worth of shares (2,000 units at $15.00), increasing direct ownership by 27% to 70,785 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:42:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buchholz Richard bought $14,840 worth of shares (1,000 units at $14.84), increasing direct ownership by 8% to 13,666 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:34:29 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CEO & Executive Chairman Ball Robert Joseph bought $33,392 worth of shares (2,200 units at $15.18), increasing direct ownership by 0.80% to 278,866 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:31:09 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    SEC Filings

    View All

    SEC Form S-1 filed by Focus Universal Inc.

    S-1 - FOCUS UNIVERSAL INC. (0001590418) (Filer)

    4/23/26 5:20:41 PM ET
    $FCUV
    Industrial Machinery/Components
    Industrials

    SEC Form DEFA14A filed by SELLAS Life Sciences Group Inc.

    DEFA14A - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)

    4/23/26 4:10:13 PM ET
    $SLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by SELLAS Life Sciences Group Inc.

    DEF 14A - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)

    4/23/26 4:09:30 PM ET
    $SLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    Leadership Updates

    Live Leadership Updates

    View All

    urban-gro, Inc. (Nasdaq: UGRO) — Sri Lanka Cricket Confirms July 10 – August 5, 2026 and Four Venues for Lanka Premier League Season 6; Tournament Conducted in Partnership with UGRO Subsidiary IPG Group

    LAFAYETTE, Colo., April 23, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., today noted the official announcement by Sri Lanka Cricket ("SLC") confirming the dates, venues, and player-registration timeline for Lanka Premier League ("LPL") Season 6. The tournament will run from July 10 to August 5, 2026, and is owned by SLC and conducted in partnership with Innovative Production Group FZ, LLC ("IPG"), the event rights holder. The Company participates in the tournament through its subsidiary, IPG under existing commercial arrangements. Season 6 — By the Numbers Tournament windowJuly 10 – August 5, 2026 (

    4/23/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    HOUSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announces that it has granted inducement awards to Eric J Daniels, M.D., its new Chief Development Officer who joined the Company on April 20, 2026. The awards were granted on April 20, 2026 under the Company's 2015 New Employee Incentive Plan, as amended, which provides for the granting of equity awards to new employees as an inducement to join the Company. The inducement awards consist of options to purchase 20,000 shares of the Company common

    4/22/26 4:30:00 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution

    HOUSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announces the appointment of Randy H. Goodman, Ph.D., M.H.A., as Vice President, Value Strategy & Health Economics and Outcomes Research (HEOR), effective April 13th, 2026. Dr. Goodman is a highly experienced health economics and market access leader with more than 20 years of experience spanning global pricing and reimbursement strategy, real-world evidence generation, and value-based healthcare modeling across the biotechnology, pharmaceutic

    4/15/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $ACDC
    $ADCT
    $ADMP
    $AG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PolyPid Ltd.

    SC 13G/A - PolyPid Ltd. (0001611842) (Subject)

    12/12/24 7:05:07 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by PolyPid Ltd.

    SC 13G/A - PolyPid Ltd. (0001611842) (Subject)

    11/29/24 1:20:33 PM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    Financials

    Live finance-specific insights

    View All

    Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

    HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announced today the initiation of manufacturing activities and technology transfer with SpectronRx under a previously executed Master Services Agreement (MSA), in support of late-stage clinical manufacturing of Rhenium-186 and REYOBIQ. With SpectronRx serving as a second GMP manufacturing site alongside Radiomedix, and Rhenium-186 isotope supplied through Telix Pharmaceuticals, Plus strengthens the reliability of its multi-partner supply chain

    4/23/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial

    Issued on behalf of Avaí Bio, Inc. Companies mentioned in this commentary include: Avaí Bio, Inc. (OTCQB:AVAI), Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Viking Therapeutics, Inc. (NASDAQ:VKTX), Longeveron Inc. (NASDAQ:LGVN). Key Takeaways: The global anti-aging market generated more than $85 billion in 2025 and is projected to approach $120 billion by 2030, with private investment in longevity science more than doubling to $8.49 billion across 325 deals last year.The U.S. FDA approved 50 new drugs in 2024 and 46 in 2025 — including what researchers are calling the first drug class of "longevity therapeutics" — while big pharma spent more than $65 billion acquiring bi

    4/23/26 6:15:00 AM ET
    $LGVN
    $LLY
    $NVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

    GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domesti

    4/22/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care